← Back to headlines
Zai Lab's Cancer Drug Zocilurtatug Pelitecan Receives FDA Fast Track Status
Zai Lab announced that its cancer drug, zocilurtatug pelitecan, has been granted Fast Track status by the U.S. Food and Drug Administration (FDA).
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
